BACE1 and Alzheimer disease: Alternatively, partial inhibition of BACE1 activity, e.g., in BACE1+/– mice, may mirror a more suitable therapeutic approach that would not impact AHN or NPC differentiation, for when BACE1 inhibition is being pursued as an effective means of lowering Aβ levels in AD.